ach-oseltamivir phosphate capsule
accord healthcare inc - oseltamivir (oseltamivir phosphate) - capsule - 30mg - oseltamivir (oseltamivir phosphate) 30mg
ach-oseltamivir phosphate capsule
accord healthcare inc - oseltamivir (oseltamivir phosphate) - capsule - 45mg - oseltamivir (oseltamivir phosphate) 45mg
ach-oseltamivir phosphate capsule
accord healthcare inc - oseltamivir (oseltamivir phosphate) - capsule - 75mg - oseltamivir (oseltamivir phosphate) 75mg
tamiflu capsules hard
f. hoffmann-la roche ltd. - oseltamivir (oseltamivir phosphate) - capsules hard - 75mg
influcein capsules hard
cjsc canonpharma production - oseltamivir (oseltamivir phosphate) - capsules hard - 75mg
tamiflu 6mgml oral suspension
roche products ltd - oseltamivir phosphate - oral suspension - 6mg/1ml
talminex oseltamivir (as phosphate) 45 mg capsule blister pack
accelagen pty ltd - oseltamivir phosphate, quantity: 59.1 mg (equivalent: oseltamivir, qty mg) - capsule, hard - excipient ingredients: titanium dioxide; croscarmellose sodium; povidone; sodium stearylfumarate; gelatin; pregelatinised maize starch; iron oxide black; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - talminex is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,talminex is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.
talminex oseltamivir (as phosphate) 30 mg capsule blister pack
accelagen pty ltd - oseltamivir phosphate, quantity: 39.4 mg (equivalent: oseltamivir, qty mg) - capsule, hard - excipient ingredients: gelatin; pregelatinised maize starch; titanium dioxide; iron oxide red; povidone; sodium stearylfumarate; iron oxide yellow; croscarmellose sodium; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - talminex is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,talminex is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.
talminex oseltamivir (as phosphate) 75 mg capsule blister pack
accelagen pty ltd - oseltamivir phosphate, quantity: 98.5 mg (equivalent: oseltamivir, qty mg) - capsule, hard - excipient ingredients: iron oxide red; croscarmellose sodium; purified talc; iron oxide black; gelatin; titanium dioxide; pregelatinised maize starch; iron oxide yellow; sodium stearylfumarate; povidone; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - talminex is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,talminex is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.
cipla-oseltamivir capsules
cipla medpro (pty) ltd - capsules - see ingredients - each capsule contains oseltamivir phosphate equivalent to oseltamivir 75,0 mg